General Information of the Compound
| Compound ID |
CP0867751
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(5R*)-N5-(4-Bromo-phenyl)-(6R*)-6-{[(1-phenyl-1H-pyrazole-5-carbonyl)-amino]-methyl}-(4S*,7R*)-[4,7-ethenylene-spiro[2.4]heptane]-5-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C27H25BrN4O2
|
||||||||||||||||||
| Molecular Weight |
517.427
|
||||||||||||||||||
| Canonical SMILES |
O=C(NC[C@H]1[C@H](C(=O)Nc2ccc(Br)cc2)[C@@H]2C=C[C@H]1C21CC1)c1ccnn1-c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H25BrN4O2/c28-17-6-8-18(9-7-17)31-26(34)24-20(21-10-11-22(24)27(21)13-14-27)16-29-25(33)23-12-15-30-32(23)19-4-2-1-3-5-19/h1-12,15,20-22,24H,13-14,16H2,(H,29,33)(H,31,34)/t20-,21-,22+,24+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
QDLZAVQOCYUGIB-SVPADUAOSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00605, FML2_HUMAN
Protein ID: PT02590, N-formyl peptide receptor 2